Extended-pulsed fidaxomicin versus vancomycin in patients 60 years and older with Clostridium difficile infection: cost-effectiveness analysis in Spain

Overview of attention for article published in European Journal of Clinical Microbiology & Infectious Diseases, April 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 45 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,426 followers.

@DrToddLee @ABsteward @CIDJournal @owenralb @Keith_S_Kaye @ErinMcCreary @jpogue1 @Dr_Cit @BradSpellberg ..disability adjusted life years. Attaching few references: https://t.co/vUhwwmcUnq https://t.co/m0IK3grkuh https://t.co/tLqLwkQUvz https://t.co/WXsw5JI

21 Sep 2022

Reply Repost Favourite

Extended-pulsed fidaxomicin versus vancomycin in patients 60 years and older with Clostridium difficile infection: cost-effectiveness analysis in Spain. https://t.co/LhfFgbxOr6 #cdiff

18 Apr 2019

Reply Repost Favourite